Houston health tech startup secured $20M in a series A round and an NIH grant amidst clinical trials.
Amount Raised
$20 Million
Round Type
Series A
HoustonHealthcareDescription
The Houston health tech startup has raised $20M in a series A funding round and received an NIH grant while conducting clinical trials.
Who else raised in Healthcare around the same time
Companies in the same sectors as VenoStent that raised within 45 days of this round, from Fundz verified event records.
- Hummingbird Healthcare raised $9.9M on May 29, 2024.
- Hummingbird Healthcare raised $1.1M on May 29, 2024.
- Soar Health raised $19M on August 15, 2024.
- HistoSonics raised $102M (Series D) on August 15, 2024.
- Pharmazz raised $7.5M on August 15, 2024.
- Pelage Pharmaceuticals raised $14M (Series A) on August 13, 2024.
Who to call at VenoStent, and when
A new round usually means VenoStent is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day VenoStent raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VenoStent, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VenoStent. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VenoStent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVenoStent raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.